Peripheral Arterial Disease Clinical Trial
— CCVSOfficial title:
The Reasons of Repolarization Disturbances Disclosure in Vascular Surgery
Verified date | June 2017 |
Source | Pomeranian Medical University Szczecin |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The vascular surgery is a highest risk procedure when considering postoperative
complications associated with the cardiovascular system. The leading clinical presentation
is acute hemodynamic decompensation. However, one of the possible pathomechanisms might be
repolarization disturbances. Many of perioperative risk factors of cardiac complications are
modifiable. The identification may help in the global perioperative risk reduction.
Aim: The aim of the study was an identification of the factors which may release clinically
overt repolarization disturbances.
Methods: The study group consisted of 100 patients, diagnosed with abdominal subrenal aortic
aneurysms or peripheral arterial disease scheduled for an elective "open" vascular surgery
procedure. The authors investigated whether age, gender, comorbidities or some perioperative
factors (including hemodynamic, metabolic or genetic) were related to the occurrence of
clinically concealed repolarization disturbances or clinically disclosed cardiac
complications in postoperative time up to 30 day and one year after vascular surgery
procedure.
Status | Completed |
Enrollment | 100 |
Est. completion date | June 2017 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - adult patients diagnosed with abdominal subrenal aortic aneurysms or peripheral arterial disease scheduled for an elective "open" vascular surgery procedure Exclusion Criteria: - heart stimulation, - atrioventricular and intraventricular conduction defects, - atrial fibrillation recorded before of the study, - antiarrhythmic drug treatment (except beta-blockers), - unoptimal patient general status (uncontrolled diabetes, active infection) - reoperation - emergency operations |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Pomeranian Medical University Szczecin |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | cardiac complications | cardiac complications according to European Society of Cardiology | up to 30 days after vascular procedure | |
Secondary | cardiac complications | cardiac complications according to European Society of Cardiology | during surgical procedure | |
Secondary | cardiac complications | cardiac complications according to European Society of Cardiology | one year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Active, not recruiting |
NCT03987061 -
MOTIV Bioresorbable Scaffold in BTK Artery Disease
|
N/A | |
Recruiting |
NCT03506633 -
Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
|
N/A | |
Active, not recruiting |
NCT03506646 -
Dietary Nitrate Supplementation and Thermoregulation
|
N/A | |
Active, not recruiting |
NCT04677725 -
NEtwork to Control ATherothrombosis (NEAT Registry)
|
||
Recruiting |
NCT05961943 -
RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients
|
N/A | |
Recruiting |
NCT06047002 -
Personalised Antiplatelet Therapy for Patients With Symptomatic Peripheral Arterial Disease
|
||
Completed |
NCT03185052 -
Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach
|
N/A | |
Recruiting |
NCT05992896 -
A Study of Loco-Regional Liposomal Bupivacaine Injection
|
Phase 4 | |
Completed |
NCT04635501 -
AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial
|
N/A | |
Recruiting |
NCT04584632 -
The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery
|
N/A | |
Withdrawn |
NCT03994185 -
The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease
|
N/A | |
Withdrawn |
NCT03538392 -
Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
|
||
Recruiting |
NCT02915796 -
Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
|
Phase 1 | |
Active, not recruiting |
NCT02900924 -
Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D
|
||
Completed |
NCT02901847 -
To Evaluate the Introduction of a Public Health Approach to Peripheral Arterial Disease (PAD) Using National Centre for Sport and Exercise Medicine Facilities.
|
N/A | |
Not yet recruiting |
NCT02455726 -
Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease
|
N/A | |
Withdrawn |
NCT02126540 -
Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries
|
N/A | |
Not yet recruiting |
NCT02387450 -
Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication
|
Phase 2/Phase 3 | |
Completed |
NCT02384980 -
Saving Life and Limb: FES for the Elderly With PAD
|
Phase 1 |